IMPROVING MEMORY IN SUBJECTS WITH MINI-MENTAL STATE EXAMINATION OF 24-26

摘要

599748 Discloses the use of Uridine or uridine phosphate and Docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA) In the manufacture of a product for improving impaired delayed recall function, for the treatment and/or prevention of an impaired delayed recall function, or improving memory and/or treatment or prevention of impaired memory function in a subject with a mini-mental state examination of 24, 25 or 26, wherein said product is enterally administered to the subject.